Evrenzo Coupon & Prices

Is NiceRx an Evrenzo coupon provider?

At NiceRx, we help eligible individuals access patient assistance programs. This means that we are not an Evrenzo coupon, an Evrenzo discount card, or an Evrenzo copay card provider. We do not offer any medication trial offers or free Evrenzo samples.

Evrenzo patient assistance program

Patient assistance programs are typically sponsored by pharmaceutical companies and provide free or discounted medications to individuals with low income who are uninsured or under-insured and meet the eligibility criteria that vary by program. There are currently no known patient assistance programs for this medication.

Can NiceRx help me get Evrenzo cheaper if I have insurance?

We may be able to help you if you have insurance, including if your insurance company will not pay for your Evrenzo medication, or if you have a high copay or coinsurance responsibility. We may even be able to assist if you do not have insurance. Please fill in our enrollment application to find out more.

How much does Evrenzo cost without insurance?

Evrenzo costs without insurance will vary depending on how much you buy and the retailer you buy it from. As a guide, Evrenzo tablets 20 mg will typically cost around $75 for 12 tablets.

How much does Evrenzo cost with insurance?

The copay of Evrenzo will vary in line with the specific terms of your healthcare plan. For further details about what you may need to pay, your insurance provider or pharmacist will be able to calculate the copay costs with your current insurance.

What is Evrenzo?

Evrenzo is manufactured by Astellas Pharma Inc, Fibrogen. Despite FDA rejection, based on cardiovascular disease risks such as blood clots and deaths, the European Commission has approved Evrenzo for adult patients with symptomatic anemia of chronic kidney disease (CKD) in both non-dialysis dependent (NDD) and dialysis-dependent (DD) adult patients.

Approval in the European Union follows the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) opinion to authorize roxadustat based on results from a Phase III open-label study.

Results from this study showed that roxadustat was effective in achieving and maintaining target Hb levels in CKD patients with symptomatic anaemia irrespective of dialysis status and of previous ESA treatment. The safety profile of roxadustat reflects that of the CKD populations studied and is comparable to ESAs. Roxadustat is approved for use in EU member states, the EEA, as well as in Japan, China, Chile, and South Korea.

It is important to note that patients treated with erythropoietin (EPO)/erythropoiesis–stimulating agent (ESA, a medicine that promotes the production of red blood cells) and whose hemoglobin levels are consistent should not be switched to Evrenzo without consulting with a healthcare professional first.

What doses of Evrenzo are available?

Evrenzo is available in tablet form, in the following doses: 20 mg, 50 mg, 70 mg, 100 mg, and 150 mg.

Always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.

Evrenzo active ingredients

Evrenzo contains the active ingredient roxadustat. It is classed as a hypoxia-inducible factor (HIF) prolyl hydroxylase (PH) inhibitor, (HIF-PH inhibitor).

Evrenzo side effects

The most common side effects of Evrenzo in clinical trials compared to placebo include:

• Hypertension (high blood pressure)
• Vascular access thrombosis (blood clots in blood vessels associated with dialysis)
• Diarrhea
• Peripheral edema (swelling in the ankles and feet)
• Hyperkalaemia (high blood potassium levels)
• Nausea

In rare instances, Evrenzo can cause more serious side effects. These can include:

• Sepsis (blood poisoning)
• Deep vein thrombosis (blood clots in a deep vein)

Your doctor will assess the benefits of using Evrenzo against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions to Evrenzo to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Evrenzo drug interactions

Other drugs may interact with Evrenzo, including prescription drugs and over-the-counter medicines, vitamins, and herbal products. Tell your health care provider about all of your medications including any supplements you are taking.

Evrenzo contraindications

You should not use Evrenzo if you:

• Are allergic to the active ingredient roxadustat
• Are allergic to any of the other ingredients in Evrenzo
• Are allergic to peanuts, or soya
• Are pregnant or are planning to become pregnant – do not use during the 3rd trimester
• Are breastfeeding or are planning to breastfeed

Talk to your doctor before using Evrenzo if you:

• Are taking any of the medications that could interact with Evrenzo

Evrenzo generic

Evrenzo is the trademark brand name for roxadustat manufactured by Astellas Pharma Inc. and Fibrogen. A generic version of roxadustat is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Evrenzo savings through NiceRx.